Bed Bath & Beyond Management
Management criteria checks 2/4
Bed Bath & Beyond's CEO is Marcus Lemonis, appointed in Mar 2025, has a tenure of 1.17 years. directly owns 0.76% of the company’s shares, worth $2.95M. The average tenure of the management team and the board of directors is 0.8 years and 5.9 years respectively.
Key information
Marcus Lemonis
Chief executive officer
US$5.9m
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 1.2yrs |
| CEO ownership | 0.8% |
| Management average tenure | less than a year |
| Board average tenure | 5.9yrs |
Recent management updates
Recent updates
Narrative Update • May 05
BBBY: Core Business Inflection And SKU Consolidation Will Support Future Repricing
Narrative Update Analysts have maintained their average $7.00 price target on Bed Bath & Beyond, with recent research citing mixed signals. Higher projected revenue growth and a very high future P/E multiple are being weighed against materially lower margin assumptions and ongoing execution uncertainty.Seeking Alpha • Apr 29
Bed Bath & Beyond: Still Unprofitable, Still Burning Through Cash
Summary Bed Bath & Beyond reported another quarter of negative GAAP net losses, heavy dilution, and cash burn. BBBY's revenue grew 7% year-over-year in the first quarter, aided by acquisitions, but gross margin declined 117 basis points to 23.9%. Recent purchases, including The Container Store and F9 Brands assets, are expected to drive revenue through 2026. BBBY is targeting $60 million in cost reductions for 2026, yet dilution and negative operating cash flow overshadow near-term growth prospects. Read the full article on Seeking AlphaNarrative Update • Apr 21
BBBY: Core Business Inflection And SKU Consolidation Will Drive Future Upside
Analysts have trimmed their average price targets for Bed Bath & Beyond to a range of about $7 to $8 from prior levels near $10 to $13, citing a mix of sequential improvement in the core business, cautious views on the execution of internal initiatives, and a valuation reset based on updated EBITDA assumptions. Analyst Commentary Recent research updates highlight that price targets for Bed Bath & Beyond have been pulled back into the high single digits, with analysts pointing to a mix of operational progress and ongoing execution risk.Narrative Update • Apr 07
BBBY: SKU Consolidation And Core Business Inflection Will Support Durable Turnaround
Analysts have trimmed Bed Bath & Beyond's average price target to a range anchored around $7 to $8. This reflects cautious views on execution risks even as they point to early signs of improvement in the core business, including SKU consolidation progress and steadier online trends.
Narrative Update • Mar 23
BBBY: Website Momentum And SKU Consolidation Will Support Multiyear Turnaround
Analysts have trimmed their average price target for Bed Bath & Beyond by $0.40. They are tying the shift to mixed Q4 takeaways, where improving core trends and SKU consolidation are being weighed against lower margin expectations and ongoing uncertainty around the multiyear turnaround plan.Narrative Update • Mar 09
BBBY: Lemonis Leadership And SKU Consolidation Will Support Renewed Core Business Momentum
Analysts have trimmed their average price target on Bed Bath & Beyond to a range around $7 to $8, reflecting updated P/E assumptions and caution around execution, even as they point to improving website trends and early traction from internal initiatives such as SKU consolidation. Analyst Commentary Recent research updates show that bearish analysts are trimming price targets even as they acknowledge some operational progress in the core business and on initiatives like SKU consolidation.Narrative Update • Feb 23
BBBY: Website Momentum And 2027 EBITDA Outlook Will Drive Upside Potential
Analysts have trimmed their fair value estimate for Bed Bath & Beyond from $10.90 to $9.80, tying the lower target to a reduced revenue outlook and higher assumed discount rate, partly balanced by expectations for slightly stronger profit margins and a higher future P/E multiple. Analyst Commentary Recent Street research highlights a mix of optimism and caution around Bed Bath & Beyond, with valuation expectations reset lower even as some early signs in the core business draw interest.Narrative Update • Feb 09
BBBY: Leadership Consolidation Under Lemonis Will Support A More Bullish Outlook
Analysts have adjusted their price target on Bed Bath & Beyond to US$7.00, reflecting small tweaks to discount rate, revenue growth, profit margin and future P/E assumptions, while keeping their overall fair value view unchanged at US$7.00. What's in the News On December 30, 2025, Bed Bath & Beyond's Board appointed Executive Chairman and principal executive officer Marcus Lemonis as Chief Executive Officer, effective January 1, 2026.Narrative Update • Jan 25
BBBY: Higher US$8 Outlook And Buybacks Will Shape A Cautious Fairly Valued Path
Narrative Update: Bed Bath & Beyond Analyst Price Target Shift Analysts have lifted their 12 month price target on Bed Bath & Beyond to US$8 from US$5, citing refreshed post earnings models that reflect updated assumptions on discount rate, revenue growth, profit margin, and future P/E. Analyst Commentary Recent commentary highlights that even with the price target increase to US$8, some research views remain cautious.Analysis Article • Jan 23
Revenues Not Telling The Story For Bed Bath & Beyond, Inc. (NYSE:BBBY) After Shares Rise 31%
Those holding Bed Bath & Beyond, Inc. ( NYSE:BBBY ) shares would be relieved that the share price has rebounded 31% in...Narrative Update • Jan 11
BBBY: Earnings Refit And Buyback Activity Set A Cautious Path Forward
Analysts lifted their price target on Bed Bath & Beyond to US$8.00 from US$5.00, citing updated earnings assumptions that reflect changes to fair value, discount rate, revenue growth, profit margin and future P/E expectations. Analyst Commentary While the updated price target of US$8.00 reflects refreshed earnings assumptions, bearish analysts still frame the stock as a higher risk proposition rather than a clear upside story.Narrative Update • Dec 14
BBBY: Margin Gains And Buyback Support Brighter Outlook Ahead
Analysts have raised their price target on Bed Bath & Beyond to $8 from $5, citing updated post-earnings models that reflect slightly higher profit margin expectations despite more modest projected revenue growth and a higher assumed future valuation multiple. Analyst Commentary Bearish analysts acknowledged that the higher price target reflects improved margin visibility following the latest earnings update, but they emphasized that the new $8 objective still implies limited upside from current levels.Analysis Article • Nov 02
Some Bed Bath & Beyond, Inc. (NYSE:BBBY) Shareholders Look For Exit As Shares Take 36% Pounding
Bed Bath & Beyond, Inc. ( NYSE:BBBY ) shareholders won't be pleased to see that the share price has had a very rough...Analysis Article • Oct 31
Bed Bath & Beyond, Inc. (NYSE:BBBY) Analysts Are Pretty Bullish On The Stock After Recent Results
Bed Bath & Beyond, Inc. ( NYSE:BBBY ) shareholders are probably feeling a little disappointed, since its shares fell...Analysis Article • Sep 09
Bed Bath & Beyond, Inc.'s (NYSE:BBBY) Shares Climb 31% But Its Business Is Yet to Catch Up
Bed Bath & Beyond, Inc. ( NYSE:BBBY ) shares have continued their recent momentum with a 31% gain in the last month...Narrative Update • Aug 07
E-commerce And Luxury Retail Trends Will Unlock Value
The increase in Beyond's consensus analyst price target from $8.80 to $10.90 is primarily driven by upward revisions in both revenue growth forecasts and future P/E multiples. What's in the News Beyond, Inc.Analysis Article • Aug 05
Health Check: How Prudently Does Beyond (NYSE:BYON) Use Debt?
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...Analysis Article • Jul 09
Revenues Not Telling The Story For Beyond, Inc. (NYSE:BYON) After Shares Rise 27%
Despite an already strong run, Beyond, Inc. ( NYSE:BYON ) shares have been powering on, with a gain of 27% in the last...Analysis Article • May 13
What Beyond, Inc.'s (NYSE:BYON) 29% Share Price Gain Is Not Telling You
Beyond, Inc. ( NYSE:BYON ) shareholders are no doubt pleased to see that the share price has bounced 29% in the last...Seeking Alpha • Apr 22
Beyond: Liberation Day Could Be A Disaster For Margins
Summary BYON faces severe financial distress with an 83% stock price drop, negative free cash flow, and liquidity issues set to be exacerbated by tariffs. The company's strategy of acquiring failed brands has not succeeded, leading to asset sales and further liquidity concerns amid recession fears. Fiscal 2024 fourth quarter revenue dropped 21.1% over its year-ago comp, missing estimates, with negative adjusted EBITDA and EPS. Liberation Day tariffs, especially a 145% tariff on Chinese imports, pose significant risks, making BYON a sell due to intense cash burn and uncertainty. Read the full article on Seeking Alpha
New Narrative • Apr 01
Expense Cuts And Vendor Consolidation Will Streamline Operations
Vendor consolidation and SG&A reductions are poised to enhance profitability and strengthen margins by streamlining operations and costs.Seeking Alpha • Mar 18
Beyond Stock.: Iconic Brands Versus Downward Trending Financials
Summary Beyond, Inc. is in a transition phase, rebranding under Bed Bath & Beyond, and aims to streamline SKUs to improve profitability amid a competitive market. Despite improving net income, Beyond, Inc. reported a 10.6% decline in revenue for 2024, marking the fourth consecutive year of revenue drops. The stock appears cheap with low valuation multiples, but significant risks and ongoing cash flow challenges warrant a cautious "hold" rating. Aggressive cost-cutting and competitive pressures from giants like Amazon and Walmart, along with macroeconomic uncertainties, pose substantial risks to Beyond, Inc.'s turnaround efforts. Read the full article on Seeking AlphaAnalysis Article • Mar 10
Some Beyond, Inc. (NYSE:BYON) Shareholders Look For Exit As Shares Take 30% Pounding
Beyond, Inc. ( NYSE:BYON ) shares have retraced a considerable 30% in the last month, reversing a fair amount of their...Seeking Alpha • Feb 07
Beyond Inc.: Analysts Overly Pessimistic, Recent Trends Likely To Reverse
Summary Beyond, Inc.'s asset-light model ensures high FCF conversion and positions the company for profitable growth as revenue scales. Leadership under Marcus Lemonis, with equity-based compensation, drives a performance-focused approach, aiming for significant stock price appreciation. Strategic partnerships and private equity investments offer synergies and mispriced optionality, enhancing Beyond's growth potential. Despite past execution missteps and cash burn concerns, market share gains and a stabilizing furniture market present a valuation opportunity. Read the full article on Seeking AlphaAnalysis Article • Jan 23
After Leaping 43% Beyond, Inc. (NYSE:BYON) Shares Are Not Flying Under The Radar
Beyond, Inc. ( NYSE:BYON ) shares have had a really impressive month, gaining 43% after a shaky period beforehand...Seeking Alpha • Jan 21
Beyond: The Perfect Turnaround Storm Could Be Unfolding
Summary CEO Marcus Lemonis, personally invested $5M, drives a focused KPI-led recovery. Trading at 0.08x EV/revenue, market pricing insolvency, clear turnaround plan, with promising early results. $65M cost cuts mostly realized, paving the path to breakeven FCF by Q3 2025. SKU realignment and targeted marketing address site conversion gaps for revenue lift. Read the full article on Seeking AlphaSeeking Alpha • Nov 13
Is It Beyond Time For Some Changes At Beyond, Inc.?
Summary Executive Chairman Marcus Lemonis has faced criticism for repeated missteps, leading to a 75% decline in BYON shares since he took over. BYON's cash adjusted market cap is down to $135 million, making it both a great acquisition target and a great candidate for a stock buyback. The company's blockchain assets, tZERO and Medici, are significantly more valuable than the retail ops based on current market values and this needs to be communicated to investors. Short interest continues to climb (16.3% of shares), indicating traders expect further declines, but some are expecting a turnaround or acquisition by a strategic investor like Ryan Cohen. Read the full article on Seeking AlphaCEO
Marcus Lemonis (51 yo)
1.2yrs
Tenure
US$5,928,963
Compensation
Mr. Marcus A. Lemonis serves as Executive Chairman of Bed Bath & Beyond, Inc. since February 20, 2024 & serves as its Principal Executive Officer since March 10, 2025 and serves as its CEO since January 01...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, Principal Executive Officer & Executive Chairman | 1.2yrs | US$5.93m | 0.76% $ 2.9m | |
| Chief Accounting Officer & Principal Accounting Officer | 1.2yrs | US$950.36k | 0.024% $ 93.4k | |
| President | less than a year | no data | 0.13% $ 502.9k | |
| Chief Financial Officer | less than a year | no data | no data | |
| Chief Operating Officer | less than a year | no data | 0.019% $ 74.8k | |
| General Counsel & Corporate Secretary | no data | no data | no data | |
| Chief People Officer | 3.3yrs | US$1.27m | no data | |
| Chief Supply Chain Officer | 4.3yrs | no data | no data | |
| Senior Vice President of Strategy | no data | no data | no data | |
| Senior VP & GM of Zulily | 2yrs | no data | no data | |
| Chief of Stores | less than a year | no data | no data | |
| Chief Executive Officer of Beyond Home Services | less than a year | no data | no data |
0.8yrs
Average Tenure
51.5yo
Average Age
Experienced Management: BBBY's management team is not considered experienced ( 0.8 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, Principal Executive Officer & Executive Chairman | 2.6yrs | US$5.93m | 0.76% $ 2.9m | |
| Independent Director | 19.2yrs | US$240.00k | 0.11% $ 412.8k | |
| Independent Director | 18.9yrs | US$240.00k | 0.24% $ 943.6k | |
| Independent Director | 5.9yrs | US$265.00k | 0.031% $ 120.8k | |
| Independent Director | 1.2yrs | US$254.62k | 0.0072% $ 28.0k | |
| Independent Director | 6.3yrs | US$240.00k | 0.054% $ 212.5k | |
| Independent Director | 3.2yrs | US$240.00k | 0.021% $ 82.1k |
5.9yrs
Average Tenure
52yo
Average Age
Experienced Board: BBBY's board of directors are considered experienced (5.9 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/05/07 18:13 |
| End of Day Share Price | 2026/05/07 00:00 |
| Earnings | 2026/03/31 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Bed Bath & Beyond, Inc. is covered by 13 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Seth Sigman | Barclays |
| Daniel Kurnos | Benchmark Company |
| Curtis Nagle | BofA Global Research |